Webinars & Events

Knome Names New CEO, Cuts Deal With Johns Hopkins to Analyze 1,000 Genomes

Luke Timmerman of Xconomy covers Knome’s announcement of a new CEO and signing of la

 

rge deal with Johns Hopkins.
Excerpt: Like a lot of biotech executives focused on developing drugs, Martin Tolar has long been skeptical of the value of genomics in bringing about personalized medicine. But over the past few months of scoping out new opportunities, he’s become enough of a believer to jump into genomics with both feet, as the new CEO of Cambridge, MA-based Knome.

“You always hear about genomics and the revolution that never happened,” Tolar says. “There was Millennium and deCode, and others who raised lots of money. But I looked at this and said, ‘No, this is incredible, it’s really happening.’ All the pieces of equation are coming together.’”

Tolar, the former CEO of Wellesley, MA-based NormOxys, is joining Knome just as it has completed its fourth year in business, which was by far its best. The company is announcing today that it has won a new contract to analyze and compare 1,000 genomes for scientists at Johns Hopkins University, who are looking for genetic variants linked to asthma in African American and African Caribbean populations. It’s the latest addition to Knome’s roster of about 100 customers for its genomic-analysis software service, although the Hopkins project is by far the biggest. Knome isn’t disclosing the value of the new project, but the company expects to generate $20 million in revenue in 2012 from academic, biotech, and pharmaceutical industry customers, Tolar says–read the full article

Follow Us On

 Events

Knome Hosts Charity Gala for Children’s Hospital Boston

On Friday, May 11, the Knome team hosted a black tie charity gala benefiting Children’s Hospital Boston. Hundreds of attendees gathered in the beautiful atrium right outside our offices here at the Davenport building in Cambridge. We were honored to have Dr. George...

Webinar: Sequence Once. Query Often.

Genomic medicine through the in silico lens of leading molecular and translational laboratoriesPresenter: Ben Salisbury, PhD, SVP of Clinical Products at KnomeDate: December 11, 2014Abstract “Sequence today for questions of today and questions of tomorrow.” In a Knome...

Webinar: The Business of Genomic Testing

Presenter: James M. Crawford, MD, PhD, Executive Director and Senior Vice President, Laboratory Services at North Shore-LIJ Health System and Professor and Chair, Department of Pathology and Laboratory Medicine at Hofstra North Shore-LIJ School of Medicine...